Silco Pharmaceuticals Limited announced earnings results for the third quarter and nine months ended period ended on 31 March 2019. For the nine months, the company's reported basic EPS of BDT 1.22 against profit after tax of BDT 78.30 million and basic EPS of BDT 1.22 for the same period of the previous year. For the quarter, the company's reported profit after tax was BDT 30.49 million compared to BDT 31.05 million for the same period a year ago. Basic EPS of BDT 0.47 compared to BDT 0.48 for the same period a year ago.